CytoSite Bio Partners with Lantheus for Innovative PET Imaging Radiotracer Development CytoSite Bio has entered a collaboration agreement with Lantheus to develop a Granzyme B-targeted PET imaging radiotracer, enhancing immunotherapy assessment. This partnership aims to pioneer advancements in monitoring immune response in oncology.

CytoSite Bio Partners with Lantheus for Innovative PET Imaging Radiotracer Development #USA #Boston #Lantheus #CytoSite_Bio #Granzyme_B